92 related articles for article (PubMed ID: 36197776)
41. Human Papillomavirus-Related Ovarian Metastasis With Endocervical Adenocarcinoma: Report of 2 Cases and Review of Literature.
Turashvili G; Farmer P; Colgan T; Childs T
J Low Genit Tract Dis; 2015 Oct; 19(4):e60-3. PubMed ID: 26360235
[TBL] [Abstract][Full Text] [Related]
42. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization.
Ren H; Pors J; Chow C; Ta M; Stolnicu S; Soslow R; Huntsman D; Hoang L
J Pathol Transl Med; 2020 Nov; 54(6):480-488. PubMed ID: 32854489
[TBL] [Abstract][Full Text] [Related]
44. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
45. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
46. Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.
Zeng Z; Austin RM; Wang L; Guo X; Zeng Q; Zheng B; Zhao C
Am J Clin Pathol; 2022 May; 157(5):718-723. PubMed ID: 34724029
[TBL] [Abstract][Full Text] [Related]
47. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
48. [Prevalence and frequencies of human papilloma virus types in adenocarcinoma in situ of the uterine cervix].
Jin J; Luo RK; Zhao J; Ning YQ; Qu X; Tao XR; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):338-343. PubMed ID: 35359046
[No Abstract] [Full Text] [Related]
49. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract][Full Text] [Related]
50. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
Fitzpatrick MB; Dube Mandishora RS; Katzenstein DA; McCarty K; Weber J; Sahoo MK; Manasa J; Chirenje ZM; Pinsky BA
Int J Infect Dis; 2019 May; 82():21-29. PubMed ID: 30807869
[TBL] [Abstract][Full Text] [Related]
51. HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix.
Baalbergen A; Smedts F; Ewing P; Snijders PJ; Meijer CJ; Helmerhorst TJ
Gynecol Oncol; 2013 Mar; 128(3):530-4. PubMed ID: 23262207
[TBL] [Abstract][Full Text] [Related]
52. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].
Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
[TBL] [Abstract][Full Text] [Related]
54. Detection of HPV-DNA by a PCR-based method in formalin-fixed, paraffin-embedded tissue from rare endocervical carcinoma types.
Nofech-Mozes S; Khalifa MM; Ismiil N; Dubé V; Saad RS; Sun P; Seth A; Ghorab Z
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):80-5. PubMed ID: 19625948
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
56. Outcome of SurePath™ cervical samples reported as borderline nuclear change by cytological subtype and high-risk HPV status.
Gupta N; Dudding N; Crossley J; Payyappilly SJ; Smith JH
Cytopathology; 2012 Dec; 23(6):402-7. PubMed ID: 22486817
[TBL] [Abstract][Full Text] [Related]
57. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
[TBL] [Abstract][Full Text] [Related]
58. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.
Stolnicu S; Park KJ; Kiyokawa T; Oliva E; McCluggage WG; Soslow RA
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S75-S91. PubMed ID: 33570865
[TBL] [Abstract][Full Text] [Related]
59. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs.
Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M
J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205
[TBL] [Abstract][Full Text] [Related]
60. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
